Effects of Tyr-D-Arg-Phe-β-Ala-NH2, a novel dermorphin analog, on elevated plus-maze learning and spontaneous alternation performance in mice

General Pharmacology

Volumn 29, Issue 3, 1997, Pages 453-456

  Ukai, Makoto ^a   Monma, Jun ^a   Shinkai, Norihiro ^a   Sasaki, Yusuke ^b   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

opioid receptor; Evaluated plus maze learning; Mouse; Spontaneous alternation performance; Tyr D Arg Phe Ala NH2

Indexed keywords

BETA FUNALTREXAMINE; DERMORPHIN DERIVATIVE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING; MALE; MOUSE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; EXPLORATORY BEHAVIOR; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED STRAINS; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; OPIOID PEPTIDES;

EID: 0030840614     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00483-1     Document Type: Article

References (23)

1. 5]enkephalin on passive avoidance behavior in mice. Behav. Neurosci. 99, 1120-1127.
2. Givens B. S. and Olton D. S. (1990) Cholinergic and GABAergic modulation of medial septal area: effect on working memory. Behav. Neurosci. 104, 849-855.
3. Haley T. J. and McCormick W. G. (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmac. 12, 12-15.
4. + channel and adenylate cyclase. Naunyn-Schmiedeberg's Arch. Pharmac. 345, 627-632.
5. Heijna M. H., Padt M., Hogenboom F., Portoghese P. S., Mulder A. H. and Schoffelmeer A. N. M. (1990) Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur. J. Pharmac. 181, 267-278.
6. Hiller J. M., Itzhak Y. and Simon E. J. (1987) Selective changes in μ-, δ- and κ-opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res. 406, 17-23.
7. Itoh J., Nabeshima T. and Kameyama T. (1990) Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 101, 27-33.
8. Itoh J., Ukai M. and Kameyama T. (1993) Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice. Eur. J. Pharmac. 234, 9-15.
9. Itoh J., Ukai M. and KameyamaT. (1994) Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the μ-selective opioid receptor agonist DAMGO in mice. J. Pharmac. Exp. Ther. 269, 15-21.
10. Izquierdo I. (1980) Effects of β-endorphin and naloxone on aquisition, memory, and retrieval of shuttle avoidance and habituation learning in rats. Psychopharmacology 69, 111-115.
11. 1-13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats. Psychopharmacology 87, 216-218.
12. Izquierdo I. and Netto C. A. (1985) Role of β-endorphin in behavioral regulation. Ann. N. Y. Acad. Sci. 444, 162-177.
13. Lapchak P. A., Araujo D. M. and Collier B. (1989) Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea pig and rat. Neuroscience 31, 313-325.
14. Ofri D., Fan L.-Q., Simon E. J. and Holler J. M. (1992) Lesioning of the nucleus basalis of Meynert has differential effects on μ-, δ- and κ-opioid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 581, 252-260.
15. Parada-Turska J. and Turski W. A. (1990) Excitatory amino acid antagonists and memory: effects of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 29, 1111-1116.
16. Rigter H., Hannan T. J., Messing R. B., Martinez Jr. J. L., Vasquez B. J., Jensen R. A., Veliquette J. and McGaugh J. L. (1979) Enkephalins interfere with acquisition of an active avoidance response. Life Sci. 26, 337-345.
17. Sarter M., Bodewitz G. and Stephens D. (1988) Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology 94, 491-495.
18. 2 and its fluorinated aromatic acid derivatives. Chem. Pharm. Bull. 39, 2316-2318.
19. Stone W. S., Walser B., Gold S. D. and Gold P. E. (1991) Scopolamine- and morphine-induced impairment of spontaneous alternation performance in mice: reversal with glucose and with cholinergic arid adrenergic agonists. Behav. Neurosci. 105, 264-271.
20. Ukai M., Kobayashi T. and Kameyama T. (1993a) Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in rats. Brain Res. 625, 355-356.
21. 2, a novel dermorphin analog with high affinity for μ-opioid receptors. Eur. J. Pharmac. 287, 245-249.
22. Ukai M., Miura M. and Kameyama T. (1995b) Effects of galanin on passive avoidance response, elevated plus-maze learning and spontaneous alternation performance in mice. Peptides 16, 1283-1286.
23. 2, a novel dermorphin analog, impairs memory consolidation in mice. Eur. J. Pharmac. 239, 237-240.